(Q42971598)

12 November 2017

title

Tegumental surface changes in adult Fasciola hepatica in response to treatment in vivo with triclabendazole in the sheep host (English)

1 reference

12 November 2017

1 reference

Fasciola hepatica

1 reference

E Toner

1

1 reference

12 November 2017

G P Brennan

2

1 reference

12 November 2017

R E B Hanna

3

1 reference

12 November 2017

H W Edgar

4

1 reference

12 November 2017

I Fairweather

5

1 reference

12 November 2017

publication date

16 May 2010

1 reference

12 November 2017

published in

Veterinary Parasitology

1 reference

12 November 2017

volume

172

1 reference

12 November 2017

issue

3-4

1 reference

12 November 2017

page(s)

238-248

1 reference

Fasciola hepatica: scanning electron microscopic observations of juvenile flukes following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide (DAMD)

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: surface and internal tegumental changes induced by treatment in vitro with the sulphoxide metabolite of albendazole ('Valbazen').

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

The speed of action of anthelmintics: mebendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: motility response to fasciolicides in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: tegumental surface alterations following treatment in vitro with the deacetylated (amine) metabolite of diamphenethide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Triclabendazole: new skills to unravel an old(ish) enigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Triclabendazole progress report, 2005-2009: an advancement of learning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

An experimental study on triclabendazole resistance of Fasciola hepatica in sheep.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

The kinetics of triclabendazole disposition in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Sheep helminth parasitic disease in south eastern Scotland arising as a possible consequence of climate change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Immature triclabendazole-resistant Fasciola hepatica: tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Surface and internal tegumental changes in juvenile Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Surface changes in adult Fasciola hepatica following treatment in vivo with the experimental fasciolicide, compound alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: tegumental surface alterations following treatment in vivo and in vitro with nitroxynil (Trodax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Triclabendazole treatment in experimental goat fasciolosis: anthelmintic efficacy and influence in antibody response and pathophysiology of the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Climate change effects on trematodiases, with emphasis on zoonotic fascioliasis and schistosomiasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Pharmacokinetic disposition of triclabendazole in cattle and sheep; discrimination of the order and the rate of the absorption process of its active metabolite triclabendazole sulfoxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver fluke Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

The activity of triclabendazole against immature and adult Fasciola hepatica infections in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Fasciola hepatica: tegumental surface changes in adult and juvenile flukes following treatment in vitro with the sulphoxide metabolite of triclabendazole (Fasinex).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

The effect of the sulphoxide metabolite of triclabendazole ('Fasinex') on the tegument of mature and immature stages of the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Anthelmintic efficacy of triclabendazole against Fasciola hepatica in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Inhibition of cytochrome P450 activity enhances the systemic availability of triclabendazole metabolites in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

Efficacy of triclabendazole against Fasciola hepatica in sheep and goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETPAR.2010.05.012

10.1016/J.VETPAR.2010.05.012

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference